Drug promotion, prescription, and value
Pharma companies say that money spent on promotion is essential to educate doctors about the best drugs - but when a medical student asked Joseph Ross, associate professor of medicine and public health at Yale, if those companies are promoting the right drugs for that message to be true, the answer wasn't available.
Ross and Tyler Greenaway, his... (Source: The BMJ Podcast)
Source: The BMJ Podcast - May 4, 2017 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Drug promotion, prescription, and value
Pharma companies say that money spent on promotion is essential to educate doctors about the best drugs - but when a medical student asked Joseph Ross, associate professor of medicine and public health at Yale, if those companies are promoting the right drugs for that message to be true, the answer wasn't available.
Ross and Tyler Greenaway, his medical student, then sat down and used the data from the US Physician Payments Sunshine Act to find out which drugs have the highest promotional budgets.
They cross referenced that against prescription databases and measures of value to assess the effectiveness, usefulness, and...
Source: The BMJ Podcast - May 4, 2017 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Johnson & Johnson Third Quarter Earnings Call and Webcast
Johnson& Johnson Third Quarter Earnings Call and Webcast (Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - October 18, 2016 Category: Pharmaceuticals Source Type: podcasts
Johnson & Johnson Second Quarter Earnings Call and Webcast
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - July 19, 2016 Category: Pharmaceuticals Source Type: podcasts
Johnson & Johnson Second Quarter Earnings Call and Webcast
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - July 19, 2016 Category: Pharmaceuticals Source Type: podcasts
DARZALEX® (daratumumab) Phase 3 data and Janssen Immuno-Oncology Strategy Webcast
DARZALEX® (daratumumab) Phase 3 data and Janssen Immuno-Oncology Strategy Webcast (Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - July 7, 2016 Category: Pharmaceuticals Source Type: podcasts
DARZALEX ® (daratumumab) Phase 3 data and Janssen Immuno-Oncology Strategy Webcast
DARZALEX & reg; (daratumumab) Phase 3 data and Janssen Immuno-Oncology Strategy Webcast (Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - July 7, 2016 Category: Pharmaceuticals Source Type: podcasts
Consumer and Medical Devices Business Review: PM Q & A
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 18, 2016 Category: Pharmaceuticals Source Type: podcasts
Consumer and Medical Devices Business Review: Medical Devices Innovation Strategy
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 18, 2016 Category: Pharmaceuticals Source Type: podcasts
Consumer and Medical Devices Business Review: AM Q&A
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 18, 2016 Category: Pharmaceuticals Source Type: podcasts
Consumer and Medical Devices Business Review: Consumer Medical Devices
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 18, 2016 Category: Pharmaceuticals Source Type: podcasts
Consumer and Medical Devices Business Review: Consumer Marketing and Innovation
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 18, 2016 Category: Pharmaceuticals Source Type: podcasts
Consumer and Medical Devices Business Review: AM Q & A
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 18, 2016 Category: Pharmaceuticals Source Type: podcasts
Consumer and Medical Devices Business Review: Consumer Overview
(Source: Johnson and Johnson Podcasts)
Source: Johnson and Johnson Podcasts - May 18, 2016 Category: Pharmaceuticals Source Type: podcasts
